First Time Loading...
C

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Watchlist Manager
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Watchlist
Price: 4.3 HKD 0.23% Market Closed
Updated: May 10, 2024
Section:
 

Relative Value

The Relative Value of one China Traditional Chinese Medicine Holdings Co Ltd stock under the Base Case scenario is 5.83 HKD. Compared to the current market price of 4.3 HKD, China Traditional Chinese Medicine Holdings Co Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5.83 HKD
Undervaluation 26%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

1.1
P/S
P/S
Price to Sales
1.1
vs History
44
vs Industry
69
Median 3Y
1
Median 5Y
1.1
Industry
2.5
Forward
0.9
More Details
15.6
P/E
P/E
Price to Earnings
15.6
vs History
19
vs Industry
31
Median 3Y
12
Median 5Y
10.8
Industry
23.4
Forward
11.1
More Details
90.2
P/OCF
P/OCF
Price to OCF
90.2
vs History
1
vs Industry
4
Median 3Y
21.4
Median 5Y
15
Industry
17.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
11
Median 3Y
-29.5
Median 5Y
-11
Industry
23.6
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
31
vs Industry
63
Median 3Y
0.9
Median 5Y
0.9
Industry
2.1
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
23
vs Industry
72
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
0.8
More Details
2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2
vs History
11
vs Industry
72
Median 3Y
1.6
Median 5Y
1.6
Industry
5.2
More Details
12.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.9
vs History
1
vs Industry
29
Median 3Y
6.1
Median 5Y
5.5
Industry
13.7
Forward
5.5
More Details
12.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.9
vs History
4
vs Industry
34
Median 3Y
7.3
Median 5Y
6.1
Industry
17.2
Forward
7.9
More Details
82.3
EV/OCF
EV/OCF
Enterprise Value to OCF
82.3
vs History
1
vs Industry
5
Median 3Y
19.8
Median 5Y
12.6
Industry
16.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
15
Median 3Y
-16.8
Median 5Y
15.6
Industry
17.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
6
vs Industry
69
Median 3Y
0.5
Median 5Y
0.5
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
China Traditional Chinese Medicine Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
21.6B HKD 1.1 15.6 12.9 12.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
733.3B USD 20.4 119.5 58.5 66.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.1 44.1 32.9 36.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
360.6B USD 4.2 9.4 11.5 15.1
US
Merck & Co Inc
NYSE:MRK
329.8B USD 5.4 143 35.6 58.2
UK
AstraZeneca PLC
LSE:AZN
192.7B GBP 5.1 38.1 174.7 278.7
CH
Roche Holding AG
SIX:ROG
180.2B CHF 3.1 15.7 8.9 10.6
CH
Novartis AG
SIX:NOVN
179.4B CHF 3.4 11.3 8.6 12.6
US
Pfizer Inc
NYSE:PFE
159.1B USD 2.9 -514.9 12.8 20.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.